| Literature DB >> 28671679 |
Ralf Fliegert1, Andreas Bauche1, Adriana-Michelle Wolf Pérez1, Joanna M Watt2,3, Monika D Rozewitz1, Riekje Winzer1, Mareike Janus1, Feng Gu1, Annette Rosche1, Angelika Harneit1, Marianne Flato1, Christelle Moreau2, Tanja Kirchberger1, Valerie Wolters1, Barry V L Potter2,3, Andreas H Guse1.
Abstract
Transient receptor potential melastatin 2 (TRPM2) is a ligand-gated Ca2+-permeable nonselective cation channel. Whereas physiological stimuli, such as chemotactic agents, evoke controlled Ca2+ signals via TRPM2, pathophysiological stimuli such as reactive oxygen species and genotoxic stress result in prolonged TRPM2-mediated Ca2+ entry and, consequently, apoptosis. To date, adenosine 5'-diphosphoribose (ADPR) has been assumed to be the main agonist for TRPM2. Here we show that 2'-deoxy-ADPR was a significantly better TRPM2 agonist, inducing 10.4-fold higher whole-cell currents at saturation. Mechanistically, this increased activity was caused by a decreased rate of inactivation and higher average open probability. Using high-performance liquid chromatography (HPLC) and mass spectrometry, we detected endogenous 2'-deoxy-ADPR in Jurkat T lymphocytes. Consistently, cytosolic nicotinamide mononucleotide adenylyltransferase 2 (NMNAT-2) and nicotinamide adenine dinucleotide (NAD)-glycohydrolase CD38 sequentially catalyzed the synthesis of 2'-deoxy-ADPR from nicotinamide mononucleotide (NMN) and 2'-deoxy-ATP in vitro. Thus, 2'-deoxy-ADPR is an endogenous TRPM2 superagonist that may act as a cell signaling molecule.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28671679 PMCID: PMC5563452 DOI: 10.1038/nchembio.2415
Source DB: PubMed Journal: Nat Chem Biol ISSN: 1552-4450 Impact factor: 15.040